Apple juice
Dietary Supplementunaltered(0% POs-Ca) commercially available apple juice
NCT Number: NCT01552252
The null hypothesis tested was that there are no differences in the taste palatability of the apple juices before and after adding POs-Ca.
Looking for future studies?
Notify Me18 year–25 year
All sexes
Interventional
Early Phase 1
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
unaltered(0% POs-Ca) commercially available apple juice
Phosphoryl Oligosaccharides of Calcium (POs-Ca) in the form of powder was added at concentrations of 0.5% by weight to a commercially available apple juice
Phosphoryl Oligosaccharides of Calcium (POs-Ca) in the form of powder was added at concentrations of 1% by weight to a commercially available apple juice
Phosphoryl Oligosaccharides of Calcium (POs-Ca) in the form of powder was added at concentrations of 1.5% by weight to a commercially available apple juice
Phosphoryl Oligosaccharides of Calcium (POs-Ca) in the form of powder was added at concentrations of 2% by weight to a commercially available apple juice
Time frame: At time when the subjects have finished drinking, an expected average of 10 minutes
Tasters were first asked to drink the unaltered (0% POs-Ca) juice, to get familiar with the taste.
After that they drank each of the 5 juices in a random order, and evaluated the taste by marking an analogue scale ranging from 0 to 100 which was printed horizontally on a sheet of paper.
Hitomi Mita
Other
Development and Evaluation of a Low Erosive Apple Juice Drink With Phosphoryl Oligosaccharides of Calcium (POs-Ca)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06648226
Behavior, Behavior, Animal
Palo Alto, California, United States
View Trial DetailsNCT06324630
Behavior, Behavior, Animal
Buffalo, New York, United States
View Trial DetailsNCT07042412
Behavior, Behavior, Animal
Al Ain City, Abu Dhabi Emirate, United Arab Emirates
View Trial DetailsNCT05907616
Behavior, Feeding Behavior
Hartford, Connecticut, United States
View Trial Details